These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23140401)

  • 1. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.
    Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K
    Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus.
    Wang H; Cao J; Lai X
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus.
    Qiu F; Song L; Ding F; Liu H; Shu Q; Yang N; Liu W; Li X
    Diagn Pathol; 2013 May; 8():88. PubMed ID: 23702100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.
    Jing C; Zhang X; Song Z; Zheng Y; Yin Y
    J Interferon Cytokine Res; 2020 Jan; 40(1):33-42. PubMed ID: 31804874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
    Brilland B; Bach-Bunner M; Gomes CN; Larochette V; Foucher E; Plaisance M; Saulnier P; Costedoat-Chalumeau N; Ghillani P; Belizna C; Delneste Y; Augusto JF; Jeannin P
    Front Immunol; 2021; 12():663192. PubMed ID: 34054830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity.
    Ye L; Ji L; Wen Z; Zhou Y; Hu D; Li Y; Yu T; Chen B; Zhang J; Ding L; Du J; Huang Z
    J Transl Med; 2014 Mar; 12():69. PubMed ID: 24629023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum interleukin-34 level in juvenile systemic lupus erythematosus and disease activity.
    El-Banna HS; El Khouly RM; Gado SE
    Clin Rheumatol; 2020 May; 39(5):1627-1632. PubMed ID: 31907692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
    Mortezagholi S; Babaloo Z; Rahimzadeh P; Namdari H; Ghaedi M; Gharibdoost F; Mirzaei R; Bidad K; Salehi E
    Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):11-18. PubMed ID: 28049380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
    Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
    Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.
    Suh CH; Hilliard B; Li S; Merrill JT; Cohen PL
    Arthritis Res Ther; 2010; 12(4):R146. PubMed ID: 20637106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
    Abdulahad DA; Westra J; Bijzet J; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2011 May; 13(3):R71. PubMed ID: 21548924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG
    Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin mediates the onset of pristane induced systemic lupus erythematosus.
    He M; Hettinghouse A; Bi Y; Chen Y; Liu C
    Adv Rheumatol; 2024 Sep; 64(1):67. PubMed ID: 39252120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Serum Interleukin-34 Level in Patients with Systemic Lupus Erythematosus Is Associated with Disease Activity.
    Xie HH; Shen H; Zhang L; Cui MY; Xia LP; Lu J
    Sci Rep; 2018 Feb; 8(1):3462. PubMed ID: 29472590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus.
    Feng X; Wang D; Chen J; Lu L; Hua B; Li X; Tsao BP; Sun L
    PLoS One; 2012; 7(12):e51982. PubMed ID: 23284839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.